MedPath

Indoor Air Quality Asthma Study: The Effect of Indoor Air Quality and Mitigation of Same on Persistent Asthma

Not Applicable
Active, not recruiting
Conditions
Persistent Asthma
Interventions
Device: Indoor Air Quality Mitigation
Registration Number
NCT05843045
Lead Sponsor
Dayton Children's Hospital
Brief Summary

The primary objective is to determine whether continuous sensing, control and mitigation of home indoor air quality influences the frequency of asthma related symptoms, as measured by Serum IgE, Spirometry with exhaled Nitric Oxide, missed school and workdays, need for pharmacologic intervention (albuterol, oral steroids), frequency of sick visits to pulmonologist or primary care provider (PCP), urgent care / emergency department visits, and hospitalizations

Detailed Description

Participants will be in the research study for approximately 2 years. There will be 11 visits to the clinic for monitoring of asthma symptoms and pulmonary function and 16 interval contacts with research staff made by either telephone or email to monitor asthma symptoms. There will also be 5 visits to participants' homes by technicians from Emerson Climate Technologies and/or an electrician in cooperation with Emerson. During these visits Emerson employees will assess participants' homes to determine if they qualify for the study and install study equipment to monitor air quality for the first half of the study and monitor and mitigate air quality for the second half of the study. At the end of the study, the technicians and/or electrician from Emerson will reset the study equipment or replace participants' original equipment, if that is their wish.

Participants will be enrolled in the research study for approximately 2 years. The first year, technicians from the study sponsor will install indoor air quality monitoring equipment in the participants' homes and information about the air quality in their home as well as baseline health and asthma information will be collected. This will be done through continuous sensing via an Atmocube air quality sensor, and a portable air quality sensor, the Atmotube. Beginning in the second half of the study, mitigation strategies of a smart home thermostat, the Sensi Touch Smart Thermostat, a smart bath fan control, the Enbrighten Z-wave Switch, and high quality furnace filter, 3M Filtrete MPR 2800 Ultrafine Particle Reduction Air Filter, will be employed. Information about the participants' asthma, health status, and air quality in the homes will continue to be collected.

Recruitment & Eligibility

Status
ACTIVE_NOT_RECRUITING
Sex
All
Target Recruitment
10
Inclusion Criteria

Child aged 5.0-15.9 years at the time of informed consent with mild, moderate, or severe persistent asthma diagnosis. In addition, participants

  • Agree to attend visits as outlined by protocol
  • Agree to respond to Asthma Control Test (ACT) and asthma control questions as outlined in protocol by telephone call, text, or email.
  • Are willing to comply with asthma treatment plan prescribed by physician.
  • Are willing to practice an acceptable form of birth control to avoid pregnancy. Acceptable forms of birth control include: true abstinence, male or female condom with or without spermicide, female barrier contraception (such as diaphragm, cervical cap, or sponge) with spermicide, continuous use of an intrauterine device throughout the study, hormonal contraceptives (including oral, patch, implanted, or injected), if used consistently and correctly throughout the study.
  • Reside in single-family dwellings and must either be homeowners or have written permission from their landlords to participate in the study.

In order to participate in the study, homes of participants must

  • have working ducted forced air HVAC systems
  • a 4-wire thermostat that is determined by Emerson technician to be capable of communicating with Sensi Touch Smart Thermostat
  • a bathroom fan switch with neutral wire and wall plate, controlling a bathroom fan that is vented to the outdoors
  • access to the internet with a modem or router.
  • A smartphone capable of pairing with the Atmotube Pro wearable sensor
Exclusion Criteria
  • Exclusion criteria: Age <5.0 or >15.9 years at the time of informed consent, inability to commit to being in the same home for the length of the study, and/or not meeting the above inclusion criteria.

Study & Design

Study Type
INTERVENTIONAL
Study Design
CROSSOVER
Arm && Interventions
GroupInterventionDescription
Indoor Air Quality MitigationIndoor Air Quality MitigationIndoor air quality mitigation strategies of a smart home thermostat, smart bath fan switch, and a high-quality furnace filter will be employed within the participants' homes. Information will continue to be collected about participants' health status and asthma symptoms as well as the air quality inside their homes.
Primary Outcome Measures
NameTimeMethod
Asthma Control Test questionnaireThrough study completion, approximately 2 years

Monthly Asthma Control Test by History. Possible scores ranging from 0 (worst control)-27 (best control) for patients ages 6-11 or 0 (worst control)- 25 (best control) for patients ages 12-16.

Secondary Outcome Measures
NameTimeMethod
oxygen saturationWeeks 1, 13, 25, 37, 49, 53, 65, 77, 89, 101, 105

percent of hemoglobin saturated by oxygen in blood

weightWeeks 1, 13, 25, 37, 49, 53, 65, 77, 89, 101, 105

weight in kilograms without shoes

respiratory rateWeeks 1, 13, 25, 37, 49, 53, 65, 77, 89, 101, 105

number of breaths per one minute

Frequency of asthma Medication UseThrough study completion, approximately 2 years

Use of asthma rescue inhaler and systemic steroids

Physical examinationWeeks 1, 13, 25, 37, 49, 53, 65, 77, 89, 101, 105

head, eyes, ears, nose, throat (HEENT), lungs, cardiovascular, abdominal, neurologic, and musculoskeletal exam by a licensed physician.

heightWeeks 1, 13, 25, 37, 49, 53, 65, 77, 89, 101, 105

standing height in centimeters without shoes

heart rateWeeks 1, 13, 25, 37, 49, 53, 65, 77, 89, 101, 105

heart beats per minute

Number of asthma related visits to Primary Care Physician, Emergency Department or Urgent CareThrough study completion, approximately 2 years

Sick Visits due to asthma

Number of missed school and work daysThrough study completion, approximately 2 years

Number of missed school and work days due to asthma symptoms

Spirometry with exhaled nitric oxideWeeks 1, 13, 25, 37, 49, 53, 65, 77, 89, 101, 105

measurement of Forced Expiratory Volume in 1 second measured quarterly

Mini Paediatric Asthma Quality of Life Questionnaire (MiniPAQLQ)Weeks 1, 49, 53, 105

Questionnaire assessing quality of life for patients with asthma. Possible scores range from 13 (worst quality of life)- 91 (best quality of life)

Concentration in serum of immunoglobulin E (IgE)Weeks 1, 53, 105

blood test measuring IgE

blood pressureWeeks 1, 13, 25, 37, 49, 53, 65, 77, 89, 101, 105

systolic over diastolic blood pressure measured in mm/Hg

Trial Locations

Locations (1)

Dayton Childrens Hospital

🇺🇸

Dayton, Ohio, United States

© Copyright 2025. All Rights Reserved by MedPath